BIAF · bioAffinity Technologies, Inc.
AI read · Good for BIAF
The AI's read
The rise suggests the test is being used more often, which could support more sales if it continues. The filing gives no dollar sales or profit figures, so the size of the financial benefit is unknown. Still, the reported sales growth and increased clinical use point in a positive direction for BIAF.